上海雅吉生物科技有限公司
首页 产品目录 产品目录(简版) 公司动态 企业认证 企业体检 公司相册 联系我们

文献引用产品|尿微量白蛋白测定试剂盒(免疫比浊法)

发布人:上海雅吉生物科技有限公司

发布日期:2026/7/13 9:20:44

  文章标题:Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies

影响因子:5.4
期刊:JOURNAL OF ETHNOPHARMACOLOGY
作者列表:Wenya Gao, Shuangrong Gao, Yan Zhang, Mengxiao Wang, Yuyang Liu, Tao Li, Chang Gao, Yanyan Zhou, Baolin Bian, Hongjie Wang, Xiaolu Wei, Takashi Sato, Nan Si, Wei Zhao, Haiyu Zhao
发表时间:2023-8-22
DOI:10.1007/s40618-022-01998-x
主要研究成果:Abstract
Ethnopharmacological relevance
Diabetic nephropathy (DN) was a major cause of end-stage renal failure and a common microvascular complication in patients with diabetes mellitus (DM). Acteoside (ACT) was the main ingredient extracted from the leaves of Rehmannia glutinosa, which had the functions of entering the lung, moisturizing the skin and relieving itching, nourishing yin and tonifying the kidney, cooling blood, and stopping bleeding. ACT had attracted worldwide interest because of its therapeutic effects on DM and its complications.
Aim of the study
To clarify the metabolic profiles and targets of ACT in db/db mice based on metabolomics and network pharmacology studies.


相关新闻资讯

文献引用产品|尿肌红蛋白定性检测试剂盒(化学法)

2026/07/13

   文章标题:Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies影响因子:5.4期刊:JOU

文献引用产品|尿微量白蛋白测定试剂盒(免疫比浊法)

2026/07/13

  文章标题:Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies影响因子:5.4期刊:JOUR

文献引用产品|大鼠白介素10(IL-10)Elisa试剂盒

2026/07/13

  文章标题:Lactobacillus fermentum CQPC08 protects rats from lead-induced oxidative damage by regulating the Keap1/Nrf2/ARE pathway影响因子:5.396期刊:Food & Function作者列表:Xingyao Long, Fengjun Sun, Zhiying Wang,